The Multiple Myeloma Research Foundation (MMRF) is grateful for the support of those who choose to establish a legacy that will accelerate groundbreaking research and the discovery of new treatments for multiple myeloma patients. Kevin Wells-Knecht, a scientist and cyclist, made such a commitment.
Kevin passed away last year, but he made sure that the multiple myeloma community received his gift and support. By including the MMRF in his estate, Kevin made a transformational gift that will advance the research and precision medicine initiatives critical to helping others diagnosed with multiple myeloma.
Kevin was diagnosed with type 1 diabetes at the age of 13 and multiple sclerosis in his early thirties. During his treatment, routine blood tests revealed that he also had multiple myeloma.
Governed by a healthy lifestyle and intense exercise—long-distance cycling—Kevin sought to use his passion for science to help find new treatments so that no one else had to share his struggle. Encouraged by his father, a chemical engineer, Kevin pursued and earned his doctorate in chemistry, studying possible mechanisms in the development of diabetic complications and, eventually, working to advance drug discovery in the fields of diabetes, oncology, and virology. In his spare time, he volunteered to counsel diabetic children struggling to cope with their disease.
Kevin’s incredible generosity gives us all hope for a future without multiple myeloma.
© Pentera, Inc. Planned giving content. All rights reserved.
Disclaimer
